Nature Communications (Feb 2024)

Flexible and cost-effective genomic surveillance of P. falciparum malaria with targeted nanopore sequencing

  • Mariateresa de Cesare,
  • Mulenga Mwenda,
  • Anna E. Jeffreys,
  • Jacob Chirwa,
  • Chris Drakeley,
  • Kammerle Schneider,
  • Brenda Mambwe,
  • Karolina Glanz,
  • Christina Ntalla,
  • Manuela Carrasquilla,
  • Silvia Portugal,
  • Robert J. Verity,
  • Jeffrey A. Bailey,
  • Isaac Ghinai,
  • George B. Busby,
  • Busiku Hamainza,
  • Moonga Hawela,
  • Daniel J. Bridges,
  • Jason A. Hendry

DOI
https://doi.org/10.1038/s41467-024-45688-z
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 16

Abstract

Read online

Abstract Genomic surveillance of Plasmodium falciparum malaria can provide policy-relevant information about antimalarial drug resistance, diagnostic test failure, and the evolution of vaccine targets. Yet the large and low complexity genome of P. falciparum complicates the development of genomic methods, while resource constraints in malaria endemic regions can limit their deployment. Here, we demonstrate an approach for targeted nanopore sequencing of P. falciparum from dried blood spots (DBS) that enables cost-effective genomic surveillance of malaria in low-resource settings. We release software that facilitates flexible design of amplicon sequencing panels and use this software to design two target panels for P. falciparum. The panels generate 3–4 kbp reads for eight and sixteen targets respectively, covering key drug-resistance associated genes, diagnostic test antigens, polymorphic markers and the vaccine target csp. We validate our approach on mock and field samples, demonstrating robust sequencing coverage, accurate variant calls within coding sequences, the ability to explore P. falciparum within-sample diversity and to detect deletions underlying rapid diagnostic test failure.